Back

Using NT-proBNP to screen patients with afib: results from the STROKESTOP II trial.

27 August 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Cardiac biomarkers are here to stay Biomarkers Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Doctor Katrin Kemp Gudmundsdottir

Landspitali University Hospital, Reykjavik (Iceland)

4 More presentations in this session

Presentation thumbnail
Introduction.
Doctor D. Gualandro (Basel, CH)
Video
Presentation thumbnail
The value of high-sensitivity troponin T in patients undergoing noncardiac surgery.
Doctor C. Puelacher (Innsbruck, AT)
Video
Presentation thumbnail
The value of NT-proBNP in cardiovascular risk stratification and optimization of cardioprotective treatment among patients with type 2 diabetes.
Doctor M. Vaduganathan (Boston, US)
Video
Presentation thumbnail
Live Q&A.
Video

Access the full session

Session thumbnail
Cardiac biomarkers are here to stay
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021
You may be interested in
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
From genetic signatures to clinical implications
thumbnail
Congress Presentation
DETECT-Heart: biomarkers for screening of patients referred to the cardiovascular outpatient clinic

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources